Douglas Richard - Jun 30, 2023 Form 4 Insider Report for Aldeyra Therapeutics, Inc. (ALDX)

Role
Director
Signature
/s/ Richard Douglas
Stock symbol
ALDX
Transactions as of
Jun 30, 2023
Transactions value $
$0
Form type
4
Date filed
7/5/2023, 05:32 PM
Previous filing
Jun 23, 2023
Next filing
Jun 6, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ALDX Stock Option (Right to Buy) Award $0 +21.2K $0.00 21.2K Jun 30, 2023 Common Stock 21.2K $8.39 Direct F1
transaction ALDX Stock Option (Right to Buy) Award $0 +5.49K $0.00 5.49K Jun 30, 2023 Common Stock 5.49K $8.39 Direct F2
transaction ALDX Stock Option (Right to Buy) Award $0 +640 $0.00 640 Jun 30, 2023 Common Stock 640 $8.39 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Board of Directors of the Issuer through the applicable vesting date.
F2 Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as the Chairperson of the Board of Directors of the Issuer through the applicable vesting date.
F3 Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Nominating/Corporate Governance Committee of the Board of Directors of the Issuer through the applicable vesting date.